ICYMI: I have always been bothered by the fact that the vast majority of patients diagnosed with #PancreaticCancer have no single attributable risk factor. How can we identify more of such at-risk individuals BEFORE they get diagnosed, often with advanced stage disease?
Grateful…

I am excited to attend the 18th Annual Symposium on #pancreaticcancer conducted by Hirshberg Foundation in #LosAngeles

We are listening to Eileen M O’Reilly from MSKCC

Thanks to Hirsberg Foundation to accept my request for registration in last minute. The ICR

#PancreaticCancer #HNSCC

aacr.org/blog/2024/04/1…

As PANCAN Awareness month draws to a close, today marks 2 years that I finished chemotherapy & surgery for stage 2 pancreatic cancer. The 2 year mark is a first major milestone to get to -🙏 for my family,friends & my doctors at PanCANNJ @PanCAN Perlmutter Cancer Center at NYU Langone Health Diane M. Simeone, MD

𝐄𝐬𝐬𝐉𝐚𝐲 𝐏𝐔𝐑𝐏𝐋𝐄 𝐏𝐔𝐑𝐏𝐎𝐒𝐄 there’s hope. More research, more funding for research!

New Phase 1 Data from Memorial Sloan Kettering Cancer Center Shows an Investigational Cancer Vaccine May Elicit Lasting Immune Response in Patients with #PancreaticCancer mskcc.org/news-releases/…

A must read review by the amazing Ralph Francescone Débora Vendramini-Costa, Ph.D (@CukiermanLab alumni and former Fox Chase Cancer Center Greenberg Pancreatic Cancer Institute ) together with Howard Crawford on #fibroblast function in #PancreaticCancer

Hot off the presses! Just wanted to share our perspective piece on fibroblasts in pancreatic cancer! Great working with wifey Débora Vendramini-Costa, Ph.D and boss Howard Crawford to convey our mindset when working with CAFs. Hope it sparks discussion! CMGH
cmghjournal.org/article/S2352-…

The Pancreatic Cancer Network's charity event, Purple Stride,occurs in 60 cities around the US on 27April. Come support all those effected by this dire disease. Or donate to Trek Against Pancreatic Caner at PurpleStride.org/teamtrek or both! Let's save lives.

Α must read article by ⁦⁦Débora Vendramini-Costa, Ph.D⁩ ⁦⁦Ralph Francescone⁩
⁦Howard Crawford⁩ 👇🏼
Rethinking the Roles of Cancer-Associated Fibroblasts in Pancreatic Cancer - Cellular and Molecular Gastroenterology and Hepatology cmghjournal.org/article/S2352-…

A pleasure to participate in this work about #PancreaticCancer that has just been published: 'Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection'. Elena Brozos Vázquez @oncomet Instituto de Invest. Sanitaria de Santiago (IDIS) IMIBIC Alipanc CIBERONC pubmed.ncbi.nlm.nih.gov/38490088/

ONLINE NOW: Exploiting pancreatic cancer metabolism: challenges and opportunities dlvr.it/T5MbSS

GI cancer specialist Dr. Shaalan Beg (@shaalanbeg) and dietician Shelli Hardy explain how pancreatic enzymes work in digestion and why pancreatic cancer patients may need them. letswinpc.org/disease-manage…

The New York City Walk for Research, presented by Northwell Health Cancer Institute, is coming up on April 21! 👟 Join us for an incredible day of hope, remembrance and action! 💜 Register or donate at lustgarten.org/NYC
#CommunityIsPower

#PancreaticCancer -associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions
nature.com/articles/s4200…

Learn about the Memorial Sloan Kettering Cancer Center #PancreaticCancer tumor registry

mskcc.org/cancer-care/cl…

MSK researchers are applying findings from single-cell technology and computational tools toward understanding and treating metastasis. At #AACR24 , dana_peer discussed results from three studies on how cellular plasticity drives cancer metastasis. More: bit.ly/3VOJeaz

According to 3-year follow up results reported at the AACR Annual Meeting 2024, immune response to autogene cevumeran, an investigational individualized neoantigen-specific mRNA vaccine, correlates with clinical benefit. 💉 Read: lfdn.org/49saWgz
#ProgressIsParamount

📢Pancreatic cancer clinical trials in #AACR24
AACR

1⃣ CT022 - Mutant KRAS peptide-based vaccine in patients at high risk of developing pancreatic cancer
✅mKRAS-specific T cell response induced

2⃣ CT134 - Neoadjuvant/adjuvant GM-CSF-secreting allogenic pancreatic tumor cell…

At the #CancerVaccines #AACR24 session? Check out this recent trial led by Dr. Shubham Pant Eileen M O’Reilly Elicio Therapeutics reporting results of a lymph node-targeting mutant #KRAS peptide vaccine given to patients with #PancreaticCancer and #ColorectalCancer nature.com/articles/s4159…